| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/11/2004 | WO2004020085A1 High density arrays |
| 03/11/2004 | WO2004020065A2 Microfluidic affinity system using polydimethylsiloxane and a surface modification process |
| 03/11/2004 | WO2004019994A1 Ark5 |
| 03/11/2004 | WO2004019981A1 Method of diffrentiation and maturation of non-nerve cells into nerve cells, agent therefor and method of searching for the agent |
| 03/11/2004 | WO2004019959A2 Dna repair enzymes |
| 03/11/2004 | WO2004019893A2 Modulators of angiogenesis |
| 03/11/2004 | WO2004019882A2 METHODS OF SCREENING FOR COMPOUNDS THAT MODULATE TAFIa ACTIVITY, COMPOUNDS, AND METHODS OF USING THE COMPOUNDS |
| 03/11/2004 | WO2004019877A2 Nos-2 and glaucoma |
| 03/11/2004 | WO2004019864A2 Quantitative rt-pcr to ac133 to diagnose cancer and monitor angiogenic activity in a cell sample |
| 03/11/2004 | WO2004007767A3 Serrs reactive particles |
| 03/11/2004 | WO2004007745A3 Method for chemiluminescent detection |
| 03/11/2004 | WO2004005922A3 Monitoring of cells |
| 03/11/2004 | WO2004003231A3 Remanent magnetic paricles capable of binding a target substance, their production and uses thereof |
| 03/11/2004 | WO2003104489A3 Mchr1 variant associated with human obesity |
| 03/11/2004 | WO2003104251A9 Composition and methods for obtaining nucleic acids from sputum |
| 03/11/2004 | WO2003097873A3 Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications |
| 03/11/2004 | WO2003097793A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/11/2004 | WO2003095662A3 Simultaneous detection of two analytes produced by a cell under the influence of a putative agent using a pin coated assay system |
| 03/11/2004 | WO2003095607A3 Role of p62 in aging-related disease |
| 03/11/2004 | WO2003093506A3 Mitochondrial polymorphisms linked to a predisposition for the development of inappropriate scarring or fibrosis |
| 03/11/2004 | WO2003091264A3 Non nucleoside reverse transcriptase inhibitors |
| 03/11/2004 | WO2003089668A3 Differentially expressed genes in conjunctivial pterygium |
| 03/11/2004 | WO2003089615A3 Antiviral inhibitions of capsid proteins |
| 03/11/2004 | WO2003080097A3 Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 7 (gpr7) |
| 03/11/2004 | WO2003078650A3 Manganese ion regulation of reverse transcriptase activity and methods of modulating same |
| 03/11/2004 | WO2003076941A3 In vitro serological method of diagnosing infective endocarditis |
| 03/11/2004 | WO2003076656A3 Use of capturing probes for identifying nucleic acids |
| 03/11/2004 | WO2003076655A3 Method for identifying a nucleic acid analyte |
| 03/11/2004 | WO2003076654A3 Method for identifying, quantifying and/or characterizing an analyte |
| 03/11/2004 | WO2003072818A3 Method for sorting single-stranded nucleic acids |
| 03/11/2004 | WO2003071268A3 Method for discovering pharmacologically active substances |
| 03/11/2004 | WO2003070966A3 RNA INTERFERENCE MEDIATED TARGET DISCOVERY AND TARGET VALIDATION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 03/11/2004 | WO2003068984A3 Reversible oxidation of protein tyrosine phosphatases |
| 03/11/2004 | WO2003066003A3 Anti-pathogen treatements |
| 03/11/2004 | WO2003064993A3 Methods and materials for detecting genetic material |
| 03/11/2004 | WO2003060155A3 Fusarium head blight resistance qtls in wheat |
| 03/11/2004 | WO2003059946A3 Genetic polymorphisms predicting cardiovascular disease and medication efficacy |
| 03/11/2004 | WO2003059155A3 Method of detecting t-cell proliferation for diagnosis of diseases by gene array |
| 03/11/2004 | WO2003057903A3 New method for analyzing, detecting, and/or monitoring the microbiological quality of a gas, device for carrying out said method, and use of said device |
| 03/11/2004 | WO2003054141A3 Sperm-specific cation channel, catsper2, and uses therefor |
| 03/11/2004 | WO2003047532A3 Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition |
| 03/11/2004 | WO2003044226A3 Method and nucleic acids for the analysis of a lymphoid cell proliferative disorder |
| 03/11/2004 | WO2003042396A3 Electronic detection of biological molecules using thin layers |
| 03/11/2004 | WO2003042351A3 A test for measuring bacteria in water |
| 03/11/2004 | WO2003038436A3 Microfluidic ser(r)s detection |
| 03/11/2004 | WO2003035826A3 Genetic screening methods |
| 03/11/2004 | WO2003034071A3 A method of forming a dynamic combinatorial library using a scaffold |
| 03/11/2004 | WO2003027671A3 Apoptosis |
| 03/11/2004 | WO2003027229A3 Antisense modulation of rip2 expression |
| 03/11/2004 | WO2003026479A3 Methods of suppressing microglial activation |
| 03/11/2004 | WO2003018799A3 Modulators of bone homeostasis identified in a high-throughput screen |
| 03/11/2004 | WO2003013431A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 03/11/2004 | WO2003012393A3 Method of detecting protease activity in a cell |
| 03/11/2004 | WO2003012100A3 Method for the production of nucleic acids consisting of stochastically combined parts of source nucleic acids |
| 03/11/2004 | WO2003008548A3 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 03/11/2004 | WO2002101350A3 Cell migration assay |
| 03/11/2004 | WO2002099063A8 Alteration of embryo/endosperm size during seed development |
| 03/11/2004 | WO2002099050A3 Tprs as modifiers of the p53 pathway and methods of use |
| 03/11/2004 | WO2002097052A3 Growth of filterable organisms that require non-diffusable media components |
| 03/11/2004 | WO2002095068A3 Engineered secreted alkaline phosphatase (seap) reporter genes and polypeptides |
| 03/11/2004 | WO2002092845A3 Method for determining enzymatic activity of glycosyl transferase |
| 03/11/2004 | WO2002083709A3 Kinases and phosphatases |
| 03/11/2004 | WO2002079512A3 Method for detection and quantification of the fungus aspergillus fumigatus using quantitative pcr |
| 03/11/2004 | WO2002079441A3 Secreted proteins |
| 03/11/2004 | US20040049799 Method for screening agents capable of treating obesity |
| 03/11/2004 | US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 03/11/2004 | US20040049021 Compositions and mehtods for treatment of Hepatitis C virus-associated diseases |
| 03/11/2004 | US20040049016 The glycoproteins induce apoptosis and can be used as a therapeutic agent against Flavivirus infection and cancer |
| 03/11/2004 | US20040049010 Transmembrane proteins |
| 03/11/2004 | US20040048826 Oligonucleotides containing 2'-0-modified purines |
| 03/11/2004 | US20040048816 Restenosis treatment |
| 03/11/2004 | US20040048808 Administering oleouropein and/or the products of its hydrolysis; inhibiting the vascularization of endothelial cells; used to treat a wide variety of cancers, ocular diseases, and inflammatory conditions. |
| 03/11/2004 | US20040048798 Especially CTL polypeptides of specific sequences |
| 03/11/2004 | US20040048778 Selective growth media |
| 03/11/2004 | US20040048396 Facilitating an activity determination for gel-based/ chromatographic-based endpoint or dose response analysis |
| 03/11/2004 | US20040048384 Method and device for collecting and stabilizing a biological sample |
| 03/11/2004 | US20040048383 Novel method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex |
| 03/11/2004 | US20040048374 Obtained by transferring a cell proliferation factor gene located between a pair of site-specific recombination sequences into a mammalian liver cell |
| 03/11/2004 | US20040048373 Production and long-term in vitro culture of these cell populations, and the use of neuroblasts in the treatment of various neuronal disorders as well as the identification of compositions which affect neuroblasts |
| 03/11/2004 | US20040048353 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 03/11/2004 | US20040048350 Crystal of bacterial core RNA polymerase with rifampicin and methods of use thereof |
| 03/11/2004 | US20040048335 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/11/2004 | US20040048334 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/11/2004 | US20040048333 Membrane/fusion proteins; PRO polypeptides; immunoglobulins; solid phase synthesis; for modulating uptake of glucose by skeletal muscle cells |
| 03/11/2004 | US20040048331 For detection of mammalian tumors; for production of Lewis Y antigens; tumor associated antigens; immunoassay; rep genes/proteins; fusion proteins |
| 03/11/2004 | US20040048330 Method for the examination of cells in a culture medium |
| 03/11/2004 | US20040048328 Multiplexed enzymatic assays |
| 03/11/2004 | US20040048326 Comprises chromogenic or fluorogenic substrates that react with esterases specific for target strains; improved translucence, stability; detecting salmonellae |
| 03/11/2004 | US20040048325 Glycosyltransferase inhibitors |
| 03/11/2004 | US20040048317 Kits comprising nucleic acids that interact with DCoH (dimerization cofactor of HNF 1 (hepatocyte nuclear factor)); for melanomas |
| 03/11/2004 | US20040048311 Use of collections of binding sites for sample profiling and other applications |
| 03/11/2004 | US20040048309 DNA from thermophilic bacterium; chromosomal replicases |
| 03/11/2004 | US20040048308 Thermostable ligase mediated DNA amplification system for the detection of genetic diseases |
| 03/11/2004 | US20040048307 Cell growth differentiation factors; for detecting increased muscle mass in food animals; kits |
| 03/11/2004 | US20040048303 Alzheimer's disease secretase, APP substrates therefor, and uses therefor |
| 03/11/2004 | US20040048301 Allele specific primer extension |
| 03/11/2004 | US20040048300 They are stable at high temperature, used in nucleic acid amplification and analysis, for improved incorporation and direct loading of nucleic acid sequencing reactions onto separating media |
| 03/11/2004 | US20040048298 An endogenous nucleic acid fragment of the retroviral type, integrated into the DNA of the human genome |
| 03/11/2004 | US20040048294 Diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins |
| 03/11/2004 | US20040048293 Useful for obtaining tumour-selective gene expression in tumours having a mutated beta -catenin pathway; used to express genes encoding therapeutic proteins in colorectal cancer cells |